Charles Schwab Investment Management Inc Charles River Laboratories International, Inc. Transaction History

Charles Schwab Investment Management Inc

$429 Billion
Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 448,809 shares of CRL stock, worth $92.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

448,809

Previous 513,227 12.55%

Holding current value

$92.7 Million

Previous $121 Million 0.23%

% of portfolio

0.03%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$203.52 - $273.43 $13.1 Million - $17.6 Million	-64,418 Reduced 12.55%	448,809 $122 Million
Q4 2023 Feb 06, 2024	BUY	$164.52 - $238.84 $3.46 Million - $5.02 Million	21,028 Added 4.27%	513,227 $121 Million
Q3 2023 Nov 08, 2023	BUY	$194.44 - $217.61 $2.15 Million - $2.41 Million	11,053 Added 2.3%	492,199 $96.5 Million
Q2 2023 Aug 09, 2023	BUY	$183.71 - $210.25 $1.32 Million - $1.51 Million	7,177 Added 1.51%	481,146 $101 Million
Q1 2023 May 11, 2023	BUY	$191.89 - $259.92 $1.99 Million - $2.69 Million	10,364 Added 2.24%	473,969 $95.7 Million

Q4 2022 Feb 13, 2023	BUY	$197.11 - $250.07 $4.42 Million - $5.61 Million	22,438 Added 5.09%	463,605 $101 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $24.5 Million - $33.7 Million	134,509 Added 43.86%	441,167 $86.8 Million
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $3.82 Million - $5.66 Million	18,733 Added 6.51%	306,658 $65.6 Million
Q1 2022 May 13, 2022	BUY	$255.51 - $362.11 $3.54 Million - $5.02 Million	13,865 Added 5.06%	287,925 $81.8 Million
Q4 2021 Feb 11, 2022	SELL	$351.38 - $448.68 $111,036 - $141,782	-316 Reduced 0.12%	274,060 $103 Million
Q3 2021 Nov 16, 2021	SELL	$372.64 - $458.3 $38.5 Million - $47.3 Million	-103,186 Reduced 27.33%	274,376 $113 Million
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $27.9 Million - $35.2 Million	94,810 Added 33.53%	377,562 $140 Million
Q1 2021 May 17, 2021	SELL	$249.67 - $299.48 $3.74 Million - $4.49 Million	-14,976 Reduced 5.03%	282,752 $82 Million
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $702,408 - $799,289	-3,164 Reduced 1.05%	297,728 $74.4 Million
Q3 2020 Nov 13, 2020	SELL	$175.56 - $226.45 $20 Million - $25.8 Million	-113,749 Reduced 27.43%	300,892 $68.1 Million
Q2 2020 Aug 14, 2020	SELL	$118.84 - $189.72 $603,350 - $963,208	-5,077 Reduced 1.21%	414,641 $72.3 Million
Q1 2020 May 15, 2020	BUY	$98.9 - $178.34 $2.18 Million - $3.93 Million	22,020 Added 5.54%	419,718 $53 Million
Q4 2019 Feb 07, 2020	BUY	$126.05 - $152.76 $999,954 - $1.21 Million	7,933 Added 2.04%	397,698 $60.8 Million
Q3 2019 Nov 08, 2019	BUY	$125.07 - $143.67 $3.86 Million - $4.44 Million	30,884 Added 8.61%	389,765 $51.6 Million
Q2 2019 Aug 09, 2019	SELL	$123.4 - $148.55 $12.6 Million - $15.1 Million	-101,910 Reduced 22.12%	358,881 $50.9 Million
Q1 2019 May 14, 2019	BUY	$104.82 - $146.73 $7.04 Million - $9.85 Million	67,125 Added 17.05%	460,791 $66.9 Million
Q4 2018 Feb 14, 2019	SELL	$105.09 - $137.23 $443,164 - $578,698	-4,217 Reduced 1.06%	393,666 $44.6 Million
Q3 2018 Nov 13, 2018	BUY	$112.11 - $134.54 $1.72 Million - $2.06 Million	15,301 Added 4.0%	397,883 $53.5 Million
Q2 2018 Aug 08, 2018	BUY	$102.37 - $117.25 $8.24 Million - $9.44 Million	80,519 Added 26.66%	382,582 $42.9 Million
Q1 2018 May 07, 2018	BUY	$98.19 - $115.2 $1.24 Million - $1.46 Million	12,670 Added 4.38%	302,063 $32.2 Million
Q4 2017 Jan 17, 2018	BUY	$100.43 - $118.09 $665,650 - $782,700	6,628 Added 2.34%	289,393 $31.7 Million
Q3 2017 Nov 13, 2017	BUY	$96.72 - $109.26 $27.3 Million - $30.9 Million	282,765	282,765 $30.5 Million

Others Institutions Holding CRL

# of Institutions

727

Shares Held

51.3M

Call Options Held

183K

Put Options Held

346K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.5B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Charles River Laboratories International, Inc. Transaction History